Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Melanoma 2 Uterine Cervical Neoplasms 1 Pancreatic Adenocarcinoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Esophageal Neoplasms 1 Brain Neoplasms 1 Advanced Unresectable or Metastatic Solid Malignancy 1

Interventions

Fluorouracil 34 Cisplatin 34 Radiotherapy 30 Oxaliplatin 30 Paclitaxel 22 pembrolizumab 20 Irinotecan 20 Docetaxel 20 Leucovorin 19 Capecitabine 16 Cetuximab 11 Carboplatin 11 Bevacizumab 11 Radiation 10 Surgical Procedures, Operative 9 Trastuzumab 8 Panitumumab 6 Epirubicin 6 Neoadjuvant Therapy 5 Esophagectomy 4 Erlotinib Hydrochloride 4 Chemotherapy, Adjuvant 4 tisotumab vedotin 3 durvalumab 3 Sunitinib 3 Microarray Analysis 3 Immunohistochemistry 3 Gene Expression Profiling 3 Gemcitabine 3 Albumin-Bound Paclitaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Esophageal Neoplasms × Tiragolumab × Clear all

NCT04540211 2026-04-09

SKYSCRAPER-08

Hoffmann-La Roche

Phase 3 Completed

461 enrolled 24 charts

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡